Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1983-3-24
pubmed:abstractText
The ability of two cloned T cell hybridomas and their products to specifically suppress the in vitro plaque-forming cell (PFC) response to the 4-hydroxy-3-nitrophenyl acetyl hapten (NP) was studied. Supernatant from one hybridoma (TS1) was shown to suppress in the induction but not the effector phase of the immune response. Supernatant from the TS1 hybridoma was capable of inducing second-order (TS2) effector-phase suppressor cells in vitro but did not suppress the response of anti-I-J plus C-treated responder cells. In contrast, supernatant from a second hybridoma (TS3) was capable of suppressing PFC responses when added either in the induction or the effector phase of the response. TS3 supernatant was unable to induce effector-phase suppressor cells but was capable of suppressing the response of anti-I-J plus C-treated responder cells. In addition, specific suppressor factors isolated from supernatants of the TS1 and TS3 hybridomas were shown to bind to NP, bear NPb idiotypic and I-J-encoded but not immunoglobulin-constant region determinants. The factor secreted by the TS3 hybridoma appears to act directly on B cell targets. Mild reduction of this factor results in two separable moieties, only one of which binds NP. Reconstitution experiments suggest that both chains are required for function. The collective data indicate that these hybridomas represent cells from first- and third-order suppressor T cell populations described previously in contact sensitivity and in vitro PFC systems. The implications of the ability of these hybridoma products to affect both T and B cell-mediated immune responses are discussed.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-15036, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-306405, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6166720, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6167654, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6170718, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6170719, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6172534, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6174662, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6174677, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6182829, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6212624, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6454741, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6454749, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6458813, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6774013, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-6997388, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-7019373, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-75231, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-79609, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-92517, http://linkedlifedata.com/resource/pubmed/commentcorrection/6185612-99320
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
157
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
515-29
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:6185612-Animals, pubmed-meshheading:6185612-Antibody-Producing Cells, pubmed-meshheading:6185612-Antigens, T-Independent, pubmed-meshheading:6185612-Complement System Proteins, pubmed-meshheading:6185612-Epitopes, pubmed-meshheading:6185612-Hemolytic Plaque Technique, pubmed-meshheading:6185612-Histocompatibility Antigens Class II, pubmed-meshheading:6185612-Hybridomas, pubmed-meshheading:6185612-Kinetics, pubmed-meshheading:6185612-Lymphokines, pubmed-meshheading:6185612-Male, pubmed-meshheading:6185612-Mice, pubmed-meshheading:6185612-Mice, Inbred C57BL, pubmed-meshheading:6185612-Nitrophenols, pubmed-meshheading:6185612-Phenylacetates, pubmed-meshheading:6185612-Rabbits, pubmed-meshheading:6185612-Suppressor Factors, Immunologic, pubmed-meshheading:6185612-T-Lymphocytes
pubmed:year
1983
pubmed:articleTitle
Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responses.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't